Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaxart | VXRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.6421 | 0.00 | 0.00 | 0.00 | 0.6421 | 07:58:37 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.50 | 0.70 | 0.20 | 28.57% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.00 | USD |
Vaxart Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 10.14M | 15.79M | $ -18.01M | -2.34 | - | 13.22M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 10.00 | 16.30% |
Vaxart News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.699 | 0.699 | 0.63 | 0.6546 | 122k | -0.0569 | -8.14% |
| 1 Month | 0.71 | 0.74 | 0.55 | 0.6686 | 171k | -0.0679 | -9.56% |
| 3 Months | 0.7 | 0.922 | 0.5223 | 0.6841 | 144k | -0.0579 | -8.27% |
| 6 Months | 2.02 | 5 | 0.5223 | 1.5845 | 598k | -1.3779 | -68.21% |
| 1 Year | 3.0999 | 7.6 | 0.5223 | 2.3993 | 419k | -2.4578 | -79.29% |
| 3 Years | 15.4 | 22 | 0.5223 | 5.1160 | 306k | -14.7579 | -95.83% |
| 5 Years | 26.95 | 33 | 0.5223 | 7.7743 | 211k | -26.3079 | -97.62% |
Vaxart Description
| Vaxart Inc is a biopharmaceutical company. It is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The company has three product candidates which are; vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics; BTA585, an oral fusion protein inhibitor for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in for condyloma caused by human papillomavirus. |
